Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening for Lung Cancer

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

(2021) Hilary A. Robbins et al.   BRITISH JOURNAL OF CANCER

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set

(2021) E.A. Klein et al.   ANNALS OF ONCOLOGY

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

(2020) Harry J. de Koning et al.   NEW ENGLAND JOURNAL OF MEDICINE

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

(2020) Anne Marie Lennon et al.   SCIENCE

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

(2020) M.C. Liu et al.   ANNALS OF ONCOLOGY

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

(2020) Charles-Hugo Marquette et al.   Lancet Respiratory Medicine

Circulating microRNAs and PD-L1 tumor expression are associated with survival in advanced NSCLC patients treated with immunotherapy: a prospective study

(2019) Mattia Boeri et al.   CLINICAL CANCER RESEARCH

Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis

(2019) M Rota et al.   ANNALS OF ONCOLOGY

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

(2019) U Pastorino et al.   ANNALS OF ONCOLOGY

Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result

(2019) Hilary A Robbins et al.   JNCI-Journal of the National Cancer Institute

Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening

(2019) U. Pastorino et al.   EUROPEAN JOURNAL OF CANCER

Lung cancer risk to personalise annual and biennial follow-up computed tomography screening

(2018) Anton Schreuder et al.   THORAX

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

(2018) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

(2018) Orazio Fortunato et al.   INTERNATIONAL JOURNAL OF CANCER

Inflammatory status and lung function predict mortality in lung cancer screening participants

(2017) Ugo Pastorino et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

European position statement on lung cancer screening

(2017) Matthijs Oudkerk et al.   LANCET ONCOLOGY

Complement C4d-specific antibodies for the diagnosis of lung cancer

(2017) Daniel Ajona et al.   Oncotarget

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening

(2016) Hormuzd A. Katki et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial

(2016) Edward F Patz et al.   LANCET ONCOLOGY

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

(2016) Uraujh Yousaf-Khan et al.   THORAX

miR-Test: A Blood Test for Lung Cancer Early Detection

(2015) Francesca Montani et al.   JNCI-Journal of the National Cancer Institute

miR-Test: A Blood Test for Lung Cancer Early Detection

(2015) Francesca Montani et al.   JNCI-Journal of the National Cancer Institute

Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study

(2014) Gabriella Sozzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

(2014) Nanda Horeweg et al.   LANCET ONCOLOGY

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers

(2014) Nanda Horeweg et al.   LANCET ONCOLOGY

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients

(2014) Orazio Fortunato et al.   MOLECULES

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial

(2013) Nanda Horeweg et al.   EUROPEAN RESPIRATORY JOURNAL

Selection Criteria for Lung-Cancer Screening

(2013) Martin C. Tammemägi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

(2013) Annette McWilliams et al.   NEW ENGLAND JOURNAL OF MEDICINE

Annual or biennial CT screening versus observation in heavy smokers

(2012) Ugo Pastorino et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

(2011) C. C. Pritchard et al.   Cancer Prevention Research

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

(2011) Mattia Boeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fleischner Society: Glossary of Terms for Thoracic Imaging

(2008) David M. Hansell et al.   RADIOLOGY